Search Results

• • 12 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• From macrophage biology to macrophage-based cellular immunotherapies.

  Authors:Elvira Mass and Nico LachmannFrom:Gene Therapy (Vol. 28, Issue 9) Peer-Reviewed

  Sept. 20212,446 words Article 1630L

   Citation Only

• Spotlight on gene therapy in Germany.

  Authors:Claudio Mussolino and Patrick HarrisonFrom:Gene Therapy (Vol. 28, Issue 9) Peer-Reviewed

  Sept. 20211,316 words Editorial 1620L

   Citation Only

• Genome editing for Duchenne muscular dystrophy: a glimpse of the future?

  Authors:Christian Kupatt, Alina Windisch, Alessandra Moretti, Eckhard Wolf, Wolfgang Wurst, and Maggie C. WalterFrom:Gene Therapy (Vol. 28, Issue 9) Peer-Reviewed

  Sept. 20215,458 words Article 1560L

   Citation Only

• CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma.

  Authors:Sabrina Prommersberger, Michael Reiser, Julia Beckmann, Sophia Danhof, Maximilian Amberger, Patricia Quade-Lyssy, et al.From:Gene Therapy (Vol. 28, Issue 9) Peer-Reviewed

  Sept. 20217,377 words Report 1690L

   Citation Only

• Cas9-directed immune tolerance in humans--a model to evaluate regulatory T cells in gene therapy?

  Authors:Dimitrios Laurin Wagner, Lena Peter, and Michael Schmueck-HenneresseFrom:Gene Therapy (Vol. 28, Issue 9) Peer-Reviewed

  Sept. 20218,620 words Article 1590L

   Citation Only

• Automated production of CCR5-negative CD4.sup.+-T cells in a GMP-compatible, clinical scale for treatment of HIV-positive patients.

  Authors:Lea Isabell Schwarze, Tanja Sonntag, Stefan Wild, Sabrina Schmitz, Almut Uhde, and Boris FehseFrom:Gene Therapy (Vol. 28, Issue 9) Peer-Reviewed

  Sept. 202110,999 words Report 1460L

   Citation Only

• Retroviral gene therapy in Germany with a view on previous experience and future perspectives.

  Authors:Michael A. Morgan, Melanie Galla, Manuel Grez, Boris Fehse, and Axel SchambachFrom:Gene Therapy (Vol. 28, Issue 9) Peer-Reviewed

  Sept. 202115,596 words Article 1730L

   Citation Only

• Targeted multi-epitope switching enables straightforward positive/negative selection of CAR T cells.

  Authors:Laura Mosti, Lukas M. Langner, Kay O. Chmielewski, Patrick Arbuthnot, Jamal Alzubi, and Toni CathomenFrom:Gene Therapy (Vol. 28, Issue 9) Peer-Reviewed

  Sept. 20217,050 words Report 1510L

   Citation Only

• Implications of hematopoietic stem cells heterogeneity for gene therapies.

  Authors:Jeremy Epah and Richard SchäferFrom:Gene Therapy (Vol. 28, Issue 9) Peer-Reviewed

  Sept. 202111,235 words Article 1620L

   Citation Only

• Optimisation of a TALE nuclease targeting the HIV co-receptor CCR5 for clinical application.

  Authors:Lea Isabell Schwarze, Dawid Glów, Tanja Sonntag, Almut Uhde, and Boris FehseFrom:Gene Therapy (Vol. 28, Issue 9) Peer-Reviewed

  Sept. 202112,810 words Report 1440L

   Citation Only

• Correction: Implications of hematopoietic stem cells heterogeneity for gene therapies.

  Authors:Jeremy Epah and Richard SchäferFrom:Gene Therapy (Vol. 28, Issue 9) Peer-Reviewed

  Sept. 202185 words Correction notice, B... 530L

   Citation Only

• Pulmonary transplantation of alpha-1 antitrypsin (AAT)-transgenic macrophages provides a source of functional human AAT in vivo.

  Authors:Ewa Janosz, Miriam Hetzel, Hanna Spielmann, Srinu Tumpara, Charlotte Rossdam, Marc Schwabbauer, et al.From:Gene Therapy (Vol. 28, Issue 9) Peer-Reviewed

  Sept. 202111,425 words Report 1500L

   Citation Only